According to an announcement from FDAnews.com, “Allergan said Monday that it has completed its $125 million purchase of San Francisco-based dry eye disease devicemaker Oculeve.” For more information on this acquisition, please visit: http://www.fdanews.com/articles/172562-allergan-completes-acquisition-of-eye-disease-devicemaker-oculeve